The global breast reconstruction meshes market is estimated to be worth USD 606.4 million in 2024 and is projected to reach a valuation of USD 1,047.1 million by 2034, expanding at a CAGR of 5.6% through 2034.
Breast cancer is the most common cancer among women in the United States, aside from skin cancers, making up about 30%, or 1 in 3, of all new cancer diagnoses in women each year. According to the American Cancer Society's projections for 2024, approximately 310,720 new cases of invasive breast cancer will be diagnosed in women.
Additionally, around 56,500 new cases of ductal carcinoma in situ (DCIS) are expected, and about 42,250 women are anticipated to die from breast cancer. Such numbers are among the primary drivers of the industry as the meshes aid in the breast surgery.
| Attributes | Description |
|---|---|
| Estimated Global Breast Reconstruction Meshes Industry Size (2024E) | USD 606.4 million |
| Projected Global Breast Reconstruction Meshes Industry Value (2034F) | USD 1,047.1 million |
| Value-based CAGR (2024 to 2034) | 5.6% |
Breast cancer primarily affects middle-aged and older women, with the median age at diagnosis being 62. This means that half of the women diagnosed with breast cancer are 62 years old or younger. Notably, a smaller proportion of women diagnosed with breast cancer are under 45 years of age.
Breast cancer is characterized by the uncontrolled growth of abnormal breast cells, which form tumors. According to the World Health Organization, in 2022, there were 2.3 million new cases of breast cancer and 670,000 deaths worldwide.
Breast cancer occurs in women of all ages after puberty, with increasing rates in later life. Breast reconstruction meshes, are thus, being used by women of varying age groups.
The rising incidence of breast cancer globally significantly drives the breast reconstruction meshes industry. The growing prevalence leads to higher demand for breast reconstruction procedures and related products, including meshes. As the incidence of breast cancer continues to climb, the necessity for effective and advanced breast reconstruction solutions becomes more pressing.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Global breast reconstruction meshes market attained a CAGR of 5.5% from 2019 to 2023. For the next ten years, from 2024 to 2034, projections are that expenditure on breast reconstruction meshes will attain a 5.6% CAGR through 2034.
There is a growing emphasis on physical appearance in society, which has led to an increase in demand for cosmetic procedures, including breast reconstruction surgery and treatment. Breast reconstruction can help women feel more confident and comfortable with their bodies after a mastectomy or lumpectomy due to breast cancer or other medical conditions.
A major driving factor for the growth of the industry is the increasing importance of physical appearance. Society places a high value on physical beauty, and many people view cosmetic procedures as a way to improve their appearance and boost their self-confidence. Breast reconstruction surgery can help women feel more confident and comfortable with their bodies, which can improve their overall quality of life.
In addition to the increasing importance of physical appearance, advancements in technology and surgical techniques have also contributed to the growth of the breast reconstruction surgery and treatment industry.
Newer techniques, such as nipple-sparing mastectomy and fat grafting, have improved the outcomes of breast reconstruction surgery and made the procedure more accessible to women.
Advances in breast reconstruction technology and techniques have led to significantly improved cosmetic outcomes, with more natural-looking results that can help restore a woman's sense of self and femininity. As women continue to place greater importance on their appearance and body image, the demand for breast reconstruction surgery is expected to grow.
The increasing emphasis on physical appearance in society is driving the growth of the breast reconstruction surgery and treatment industry. Breast reconstruction surgery can help women feel more confident and comfortable with their bodies, which can improve their overall quality of life.
The industry is expected to continue to grow in the coming years due to advancements in technology and surgical techniques, as well as increasing demand for the procedure.
Tier 1 companies in the global breast reconstruction mesh market include prominent names such as Allergan, Johnson & Johnson, and Stryker. They are developing improved mesh materials, increasing product portfolios, and pursuing strategic acquisitions.
They aim to enhance mesh biocompatibility, tissue integration, and surgical results. These corporations additionally make investments in clinical research and work with healthcare experts on product development. In 2024, tier 1 companies are anticipated to acquire a 63.9% market share owing to the above factors.
Tier 2 companies are aiming for scalability by prioritizing cost-effective production, increasing product differentiation, and entering new markets. They use novel technologies and materials to increase mesh performance and compete with Tier 1 companies. These companies also prioritize strategic relationships and cooperation with medical experts and institutions to expand their industry presence.
Tier 2 enterprises hope to increase industry share and growth by investing in research and development and developing distribution networks. The tier 2 companies are likely to garner a 23.2% market share in 2024. A few of the tier 2 companies include SERAG-WIESSNER GmbH & Co. KG, Novus Scientific, PFM medical, Cook Biotech, and MedSkin Solutions Dr. Suwelack AG.
Tier 3 companies in the breast reconstruction mesh industry, like Advanced Biomedical Concept Srl and Biomedica, play critical roles by emphasizing niche markets and specialized products. They frequently propose novel, specialized solutions that address unique patient demands and surgical approaches.
These firms promote competition, innovation, and individualized customer service, all of which contribute to the overall diversity and progress of the industry. They may also function as nimble, adaptive partners in cooperation with larger corporations and research institutes.
Principal Consultant
The following table shows the estimated growth rates of the top three markets. The United States, India and the United Kingdom are set to exhibit dominance in breast reconstruction industry, recording CAGRs of 5.4%, 4.5% and 4.4%, respectively, through 2034.
| Countries | CAGR 2024 to 2034 |
|---|---|
| USA | 5.4% |
| India | 4.5% |
| UK | 4.4% |
| Germany | 4.8% |
| China | 5.3% |
The industry for breast reconstruction meshes in the United States is projected to exhibit a CAGR of 5.4% during the assessment period. By 2034, breast reconstruction meshes industry size in the country is expected to reach USD 468.7 million.
The United States dominates the breast reconstruction industry due to a high prevalence of breast cancer, advanced medical technologies, supportive healthcare policies, and leading industry players like Johnson & Johnson and Allergan driving innovation and accessibility.
The market for breast reconstruction meshes in the India is projected to exhibit a CAGR of 4.5% during the assessment period. By 2034, breast reconstruction meshes market size in the country is expected to reach USD 27.9 million.
India has been continuously improving its healthcare infrastructure, including the adoption of advanced surgical techniques and medical devices. This enhancement facilitates the use of sophisticated products like breast reconstruction meshes.
Indian manufacturers and healthcare providers are incorporating the latest technologies in mesh production and surgical procedures, ensuring higher success rates and better patient outcomes. Such factors collectively make India a significant player in the breast reconstruction meshes industry.
The industry for breast reconstruction meshes in the United Kingdom is projected to exhibit a CAGR of 4.4% during the assessment period. By 2034, breast reconstruction meshes market size in the country is expected to reach USD 52.3 million.
The United Kingdom has a significant number of breast cancer cases, increasing the demand for breast reconstruction procedures that often utilize meshes.
The regional healthcare infrastructure, including the National Health Service (NHS), supports advanced surgical techniques and provides widespread access to breast reconstruction options, promoting the use of reconstruction meshes. Such factors collectively position the United Kingdom as a significant player in the breast reconstruction meshes industry.
| Segment | Polypropylene (Form Product) |
|---|---|
| Value Share (2024) | 32.1% |
The industry value of synthetic mesh in breast reconstruction meshes is USD 318.6 million, representing a sizable 55.4% market share in 2023.
Synthetic meshes are generally less expensive compared to biological alternatives, making them a preferred choice in many healthcare systems. This cost advantage extends their accessibility and usage in various reconstructive procedures.
Advances in the materials used for synthetic meshes, such as titanium-coated polypropylene (e.g., TiLOOP), have improved their biocompatibility. These meshes show good integration with surrounding tissues and reduced inflammatory responses, which enhances their safety and effectiveness in breast reconstruction
| Segment | Absorbable Mesh (From Nature) |
|---|---|
| Value Share (2024) | 32.8% |
The industry value of absorbable mesh in breast reconstruction meshes is USD 188.8 million, representing a sizable 32.8% market share in 2023.
Absorbable meshes integrate well with natural tissue, reducing long-term complications. They tend to have lower rates of infection and other post-surgical complications compared to permanent meshes.
Innovations like the TIGR Matrix provide staged degradation, offering temporary support while gradually being absorbed, leading to better aesthetic outcomes. Advantages as such contribute to the growing preference for absorbable meshes in breast reconstruction surgeries.
| Segment | Implant-based reconstruction (Form Application) |
|---|---|
| Value Share (2024) | 24.0% |
Implant-based reconstruction is projected to register a CAGR of 4.8% from 2024 to 2034.
Implant-based reconstructions are highly preferred post-mastectomy due to their effectiveness in achieving desired aesthetic outcomes. Innovations in implant materials and techniques, such as the use of synthetic meshes and acellular dermal matrices (ADMs), enhance procedural success and patient satisfaction.
These factors collectively contribute to the leading position of implant-based reconstruction in the breast reconstruction meshes market.
| Segment | Hospitals (Form End User) |
|---|---|
| Value Share (2024) | 29.6% |
Hospitals is projected to register a CAGR of 4.6% from 2024 to 2034.
Hospitals typically procure and utilize various medical devices and products, including breast reconstruction meshes, to provide reconstructive surgeries for patients who have undergone mastectomies due to breast cancer or other medical reasons.
As leading end-users in the breast reconstruction meshes market, hospitals are responsible for assessing the quality, efficacy, and safety of these products.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The breast reconstruction meshes ecosystem encompasses a diverse and dynamic competitive landscape. Leading meshes manufacturing companies are focusing on research and development, sustainable sourcing, and new formulations and biomaterials.
They are also emphasizing environment-friendly practices and product certifications to satisfy the increasing demand for natural and sustainable ingredients.
Manufacturers are also looking to preserve their market position by focusing on product quality, innovation, and matching varied customer preferences. Such mesh producers are working on innovating new biomaterials and combination of therapies which can be used in their products for added benefits.
For instance
As per product, the industry has been categorized into Synthetic Mesh- (Polypropylene, Polyester (Polyethylene Terephthalate, PET), Polytetrafluoroethylene (PTFE), Polyvinylidene Fluoride (PVDF) and Expanded Polytetrafluoroethylene (ePTFE). Biological Mesh- (Bovine [Bovine Pericardium, Bovine Collagen]), (Porcine [Porcine Skin, Porcine Small Intestine] & Human
This segment is further categorized into absorbable mesh, nonabsorbable mesh, resorbable surgical mesh and non resorbable surgical mesh
Different applications include implant-based reconstruction, autologous tissue reconstruction, pre-pectoral reconstruction, sub-pectoral reconstruction, revision surgeries and congenital asymmetry/deformity surgery.
The end user segment includes hospitals, ambulatory surgical centers, speciality clinics, comprehensive cancer centers, plastic surgery clinics and academic & research institutes
Industry analysis has been carried out in key countries of North America, Latin America, East Asia, South Asia & Pacific, Western Europe, Eastern Europe and Middle East & Africa
The global breast reconstruction meshes industry is estimated at a value of USD 575.0 million in 2024.
The global breast reconstruction meshes industry registered the historic CAGR of 3.4% from 2019 to 2023.
SERAG-WIESSNER GmbH & Co. KG, Novus Scientific, pfm medical, Allergan Aesthetics, Cook Biotech, MedSkin Solutions Dr. Suwelack AG, Tutogen Medical GmbH, Becton, Dickinson and Company, RTI Surgical, Stryker Corporation, PolyNovo, MTF Biologics, Tissue Regenix, Aziyo Biologics, Advanced Biomedical Concept Srl and Biomedica.
The North American industry is projected to hold a revenue share of 44.1% over the forecast period.
Europe to hold 24.1% share of the global industry for breast reconstruction meshes.
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034 5.1. By Product 5.2. By Nature 5.3. By Application 5.4. By End User 5.5. By Region 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Product 6.1. Synthetic Mesh 6.1.1. Polypropylene 6.1.2. Polyester (Polyethylene Terephthalate, PET) 6.1.3. Polytetrafluoroethylene (PTFE) 6.1.4. Polyvinylidene Fluoride (PVDF) 6.1.5. Expanded Polytetrafluoroethylene (ePTFE) 6.2. Biological Mesh 6.2.1. Bovine 6.2.1.1. Bovine Pericardium 6.2.1.2. Bovine Collagen 6.2.2. Porcine 6.2.2.1. Porcine Skin 6.2.2.2. Porcine Small Intestine 6.2.3. Human 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Nature 7.1. Absorbable Mesh 7.2. Nonabsorbable Mesh 7.3. Resorbable Surgical Mesh 7.4. Non-Resorbable Surgical Mesh 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Application 8.1. Implant-based Reconstruction 8.2. Autologous Tissue Reconstruction 8.3. Pre-Pectoral Reconstruction 8.4. Sub-Pectoral Reconstruction 8.5. Revision Surgeries 8.6. Congenital Asymmetry/Deformity Surgery 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by End User 9.1. Hospitals 9.2. Ambulatory Surgical Centers 9.3. Specialty Clinics 9.4. Comprehensive Cancer Centers 9.5. Plastic Surgery Clinics 9.6. Academic & Research Institutes 10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region 10.1. North America 10.2. Latin America 10.3. Western Europe 10.4. Eastern Europe 10.5. East Asia 10.6. South Asia and Pacific 10.7. Middle East and Africa 11. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 12. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 13. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 14. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 15. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 16. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 17. Middle East and Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries 18. Sales Forecast 2024 to 2034 by Product, Nature, Application, and End User for 30 Countries 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 20. Company Profile 20.1. SERAG-WIESSNER GmbH & Co. KG 20.2. Novus Scientific 20.3. pfm medical 20.4. Allergan Aesthetics 20.5. Cook Biotech 20.6. MedSkin Solutions Dr. Suwelack AG 20.7. Tutogen Medical GmbH 20.8. Becton, Dickinson and Company 20.9. RTI Surgical 20.10. Stryker Corporation 20.11. PolyNovo 20.12. MTF Biologics 20.13. Tissue Regenix 20.14. Aziyo Biologics 20.15. Advanced Biomedical Concept Srl 20.16. Biomedica
Explore Healthcare Insights
View Reports
Breast Reconstruction Meshes Market
